Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Cash & Equivalents: 2021-2024

Historic Cash & Equivalents for Aveanna Healthcare Holdings (AVAH) over the last 4 years, with FY2024 value amounting to $84.3 million.

  • Aveanna Healthcare Holdings' Cash & Equivalents rose 8590.66% to $145.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.9 million, marking a year-over-year increase of 8590.66%. This contributed to the annual value of $84.3 million for FY2024, which is 9181.65% up from last year.
  • As of FY2024, Aveanna Healthcare Holdings' Cash & Equivalents stood at $84.3 million, which was up 9181.65% from $43.9 million recorded in FY2023.
  • Over the past 5 years, Aveanna Healthcare Holdings' Cash & Equivalents peaked at $137.3 million during FY2021, and registered a low of $19.2 million during FY2022.
  • Its 4-year average for Cash & Equivalents is $63.1 million, with a median of $43.9 million in 2023.
  • Per our database at Business Quant, Aveanna Healthcare Holdings' Cash & Equivalents tumbled by 7780.04% in 2022 and then soared by 12866.21% in 2023.
  • Over the past 4 years, Aveanna Healthcare Holdings' Cash & Equivalents (Annual) stood at $137.3 million in 2021, then plummeted by 86.01% to $19.2 million in 2022, then surged by 128.66% to $43.9 million in 2023, then skyrocketed by 91.82% to $84.3 million in 2024.
  • Its last three reported values are $84.3 million in FY2024, $43.9 million for FY2023, and $19.2 million during FY2022.